BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36786170)

  • 1. SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.
    Lahera A; López-Nieva P; Alarcón H; Marín-Rubio JL; Cobos-Fernández MÁ; Fernández-Navarro P; Fernández AF; Vela-Martín L; Sastre I; Ruiz-García S; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
    Br J Haematol; 2023 May; 201(4):718-724. PubMed ID: 36786170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
    Teramo A; Gattazzo C; Passeri F; Lico A; Tasca G; Cabrelle A; Martini V; Frezzato F; Trimarco V; Ave E; Boscaro E; Piazza F; Facco M; Trentin L; Semenzato G; Zambello R
    Blood; 2013 May; 121(19):3843-54, S1. PubMed ID: 23515927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
    Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
    Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
    J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
    Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
    PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of JAK/STAT pathway in the induction of cell cycle arrest in macrophages infected with periodontopathic bacterium Aggregatibacter actinomycetemcomitans.
    Okinaga T; Ariyoshi W; Akifusa S; Nishihara T
    Med Microbiol Immunol; 2013 Apr; 202(2):167-74. PubMed ID: 23266654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic role of microRNA-19b-3p-mediated SOCS3 in glioma through activation of JAK-STAT pathway.
    Li T; Ge H; Yang Q; Wang J; Yin Q; Wang H; Hou G
    Metab Brain Dis; 2023 Mar; 38(3):945-960. PubMed ID: 36484970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
    Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
    Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
    Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
    J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the JAK-STAT pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage RAW 264 cells.
    Akifusa S; Kamio N; Shimazaki Y; Yamaguchi N; Nonaka K; Yamashita Y
    J Cell Biochem; 2010 Oct; 111(3):597-606. PubMed ID: 20564237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
    Liu K; Wu Z; Chu J; Yang L; Wang N
    Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.
    Sharma ND; Nickl CK; Kang H; Ornatowski W; Brown R; Ness SA; Loh ML; Mullighan CG; Winter SS; Hunger SP; Cannon JL; Matlawska-Wasowska K
    Cancer Sci; 2019 Jun; 110(6):1931-1946. PubMed ID: 30974024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
    Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressors of cytokine signaling abrogate diabetic nephropathy.
    Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.